Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
Br J Haematol
; 173(6): 867-75, 2016 06.
Article
in En
| MEDLINE
| ID: mdl-26970533
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
Rituximab
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2016
Type:
Article
Affiliation country:
United States